L-Phenylalanine concentration in blood of phenylketonuria patients: A modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 9, 2010, Pages 1271-1279

  De Silva, Veronica ^a   Oldham, Charlie D ^a   May, Sheldon W ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

enzyme colorimetric analysis; hyperphenylalaninemia; phenylalanine; phenylalanine dehydrogenase

Indexed keywords

PHENYLALANINE; SOLVENT;

ADOLESCENT; ADULT; AMINO ACID ANALYSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DEVICE; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; AMINO ACID OXIDOREDUCTASES; CALIBRATION; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORIMETRY; FEMALE; HUMANS; MIDDLE AGED; PHENYLALANINE; PHENYLKETONURIAS; SPOROSARCINA; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 77957320788     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.271     Document Type: Article

References (38)

1. Waters PJ. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 2003;21:357-69.
2. Scriver CR, Clow CL. Phenylketonuria: epitome of human biochemical genetics. New Engl J Med 1980;303:1336-42.
3. Scriver CR. Whatever happened to phenylketonuria? Clin Biochem 1995;28:137-44.
4. National Institute of Health Consensus Development Panel. National Institute of Health Consensus Development Conference Statement: Phenylketonuria: screening and management. Pediatrics 2000;108:972-82.
5. Surtees R, Blau N. The neurochemistry of phenylketonuria. Eur J Pediatr 2000;159: S109-13.
6. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43.
7. McCaman NW, Robins E. Fluorimetric method for determination of phenylalanine in serum. J Lab Clin Med 1962;59:885-90.
8. Rivero A, Allué JA, Grijalba A, Palacios M, Merlo SG. Comparison of two different methods for measurement of phenylalanine in dried blood spots. Clin Chem Lab Med 2000;38:773-6.
9. Slocum RH, Cummings JG. Amino acid analysis of physiological samples. In: Hommes FA, editor. Techniques in diagnostic human biochemical genetics. New York: Wiley-Liss, 1991:87-126.
10. Ceglarek U, Muller P, Stach B, Buhrdel P, Joachim T, Kiess W. Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 2002;40:693-7. (Pubitemid 34982479)
11. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;39:66-71. (Pubitemid 23034958)
12. Dale Y, Mackey V, Mushi R, Nyanda A, Maleque M, Ike J. Simultaneous measurement of phenylalanine and tyrosine in phenylketonuric plasma and dried blood by high-performance liquid chromatography. J Chromatogr B 2003;788:1-8. (Pubitemid 36369105)
13. Shen R-S, Abell CW. Phenylketonuria: a new method for the simultaneous determination of plasma phenylalanine and tyrosine. Science 1977;197:665-7.
14. McKnight RP, Willis JE, Shen R-S, Abell CW. Evaluation of the PaT Stat kinetic UV test set for the determination of phenylalanine and tyrosine in serum or plasma. Clin Biochem 1983;16:157-62.
15. Wibrand F. A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum. Clin Chim Acta 2004;347:89-96. (Pubitemid 39099609)
16. Campbell RS, Brearly GM, Varsani H. Development and validation of a robust specific enzyme mediated assay for phenylalanine in serum. Clin Chim Acta 1992;210:197-210.
17. Campbell RS, Hollifield RD, Varsani H, Milligan TP, Brearley G, Price CP. Development of an enzyme-mediated assay for phenylalanine in blood spots. Ann Clin Biochem 1994;31:140-6. (Pubitemid 24113901)
18. Fingerhut R, Stehn M, Kohlschütter A. Comparison of four different phenylalanine determination methods. Clin Chim Acta 1997;264:65-73. (Pubitemid 27336994)
19. Keffler S, Denmeade R, Green A. Neonatal screening for phenylketonuria: evaluation of an automatic enzymatic method. Ann Clin Biochem 1994;31:134-9. (Pubitemid 24113900)
20. Randell EW, Lehotay DC. An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria. Clin Biochem 1996;29:133-8. (Pubitemid 126334363)
21. Schulze A, Mayatepek E, Hoffmann GF. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. Clin Chim Acta 2002;317:27-37. (Pubitemid 34114015)
22. Taylor RP, Smith IC, Standing SJ. Rapid automated enzymatic measurement of phenylalanine in plasma and blood spots. Clin Chim Acta 1993;218:207-14.
23. Wendel U, Hummel W, Langenbeck U. Monitoring of phenylketonuria: a colorimetric method for the determination of plasma phenylalanine using L-phenylalanine dehydrogenase. Anal Biochem 1989;180:91-4. (Pubitemid 19200566)
24. Wendel U, Koppelkamm M, Hummel W, Sander J, Langenbeck U. A new approach to the newborn screening for hyperphenylalaninemia: use of L-phenylalanine dehydrogenase and microtiter plates. Clin Chim Acta 1990;192:165-70. (Pubitemid 20375839)
25. Pérez-Dueñas B, Vilaseca MA, Mas A, Lambruschini N, Artuch R, Gómez L, et al. Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Clin Biochem 2004;37:1083-90. (Pubitemid 39601096)
26. Cohen SA, De Antonis KM. Applications of amino acid derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Analysis of feed grains, intravenous solutions and glycoproteins. J Chromatogr A 1994;661:25-34.
27. Cohen SA, Michaud DP. Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal Biochem 1993;211:279-87.
28. Vollmer DV, Jinks DC, Guthrie R. Isocratic reverse-phase liquid chromatography assay for amino acid metabolic disorders using eluates of dried blood spots. Anal Biochem 1990;189:115-21. (Pubitemid 20262987)
29. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
30. Gregory CO, Yu C, Singh RH. Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods. Genet Med 2007;9:761-5. (Pubitemid 350129411)
31. Asano Y, Nakazawa A, Endo K. Novel phenylalanine dehydrogenase from Sporosarcina ureae and Bacillus sphaericus. J Biol Chem 1987;262:10346-54.
32. +-dependent dehydrogenases based on reduction of a tetrazolium dye to its soluble formazan. Anal Biochem 1997;250:253-5. (Pubitemid 27319105)
33. Chace DH, Adam BW, Smith SJ, Alexander JR, Hillman SL, Hannon WH. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clin Chem 1999;45:1269-77.
34. Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH, et al. Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clin Chem 2000;46:126-8.
35. Koch R, Hanley W, Levy H, Matalon R, Rouse B, Trefz F, et al. Maternal phenylketonuria: an international study. Mol Genet Metab 2000;71:233-9.
36. Jardim LB, Palma-Dias R, Silva LC, Ashton-Prolla P, Giugliani R. Maternal hyperphenylalaninemia as a cause of microcephaly and mental retardation. Acta Paediatr 1996;85:943-6. (Pubitemid 26273840)
37. MacDonald A. Diet and compliance in phenylketonuria. Eur J Pediatr 2000;159(Suppl 2): S136-41.
38. Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, et al. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 1999;103:1169-78. (Pubitemid 29207251)